Agilent NGS QC Featured Content
-
Separation Of cfDNA With An NGS Kit On Fragment Analyzer Systems
3/19/2026
Learn how precise sizing methods reveal nucleosome patterns in cfDNA and help distinguish true signal from extraction‑related artifacts for more reliable genomic analysis.
-
NGS Analysis Of Hereditary Cancer Predispositions
3/4/2026
Examine how a molecular genetics team improves NGS efficiency and library quality through streamlined automation, intuitive QC tools, and reliable workflows, boosting reproducibility.
-
Advancing Genomic Discoveries With Comprehensive Sequencing Support
3/4/2026
See how a leading genomics facility advances long‑read sequencing through rigorous QC and flexible workflows, offering practical insights for researchers aiming to improve sequencing outcomes.
-
Detection Of Adapter Dimers In NGS Libraries
3/4/2026
Accurately identifying low‑level adapter dimers is key. Compare electrophoresis methods to show how different kits detect and resolve small fragments, helping researchers choose the best QC approach.
-
Comparison Of Constant- And PulsedField Electrophoresis
3/4/2026
Accurate sizing of large DNA fragments is crucial in long‑read sequencing. Examine how different electrophoresis methods perform with 10–20 kb smears and how to choose the most reliable approach.
-
Preventive Control Of Sequencing Through The Insert
3/4/2026
Understanding library size distributions helps prevent sequencing through the insert, reducing adapter read‑through. Explore how smear analysis guides optimal read‑length selection to avoid noise.
-
Sample Quality Control In Next-Generation Sequencing Workflows
3/4/2026
See how automated electrophoresis and key integrity metrics strengthen NGS workflows by improving sample assessment, streamlining QC steps, and supporting confident decisions.
-
How Automated NGS Solutions Advance Rare Disease Research
2/27/2026
See how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.